Nasal Congestion Clinical Trial
The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
Subjects will screen at St. Luke's Hospital in San Francisco to determine their eligibility.
Once enrolled the study will take two weeks. During the first week subjects attend daily,
hour-long outpatient visits at San Francisco General Hospital. At these visits subjects will
receive an oral dose of l-methamphetamine, have their vitals read, answer questionnaires and
receive a blood draw.
During the second week of the study subjects are admitted to San Francisco General Hospital
for a week long inpatient stay. During this stay the subject continues to receive
l-methamphetamine but also receives three doses of d-methamphetamine on three separate days.
In addition the subject receives blood draws, has their urine collected, and answers
questionnaires.
;
Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00665977 -
Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure
|
Phase 3 | |
| Completed |
NCT05843071 -
PMCF Study to Evaluate Performance and Safety of "NASAL SPRAYS " Used to Relieve Nasal Congestion and Dryness
|
N/A | |
| Completed |
NCT00957996 -
Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
|
Phase 3 | |
| Completed |
NCT00662337 -
Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride
|
Phase 1 | |
| Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
| Recruiting |
NCT05244148 -
Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects
|
N/A | |
| Completed |
NCT05159271 -
Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults
|
N/A | |
| Completed |
NCT02113449 -
Market Potential of Carbon Dioxide Nasal Spray
|
Phase 2 | |
| Terminated |
NCT00958776 -
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
|
Phase 3 | |
| Completed |
NCT00648973 -
To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses
|
Phase 4 | |
| Completed |
NCT03399721 -
Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis
|
N/A | |
| Completed |
NCT01354418 -
Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED)
|
Phase 1 | |
| Completed |
NCT04797936 -
BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19
|
Phase 4 | |
| Completed |
NCT03906968 -
The Safety and Efficacy of a SinuSonic Intervention
|
N/A | |
| Completed |
NCT02100605 -
Study on Hypertonic Saline Nasal Spray
|
N/A | |
| Recruiting |
NCT06323304 -
Efficacy and Safety of Auricular Acupressure in Treating Allergic Rhinitis
|
N/A | |
| Withdrawn |
NCT04790487 -
Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
|
Phase 2/Phase 3 | |
| Completed |
NCT01448057 -
Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu
|
Phase 3 | |
| Completed |
NCT01129765 -
Home Usability of a Nasal Lavage System in Children
|
N/A | |
| Completed |
NCT04910139 -
A User Study of the Soniflow System for Nasal Congestion Relief
|
N/A |